A team of researchers discovered a new therapy for the reduction of lung inflammation in cystic fibrosis.
Researchers from Stanford University developed a new method to screen newborn from cystic fibrosis through blood test.
A new combination drug called Orkambi has been approved by the FDA and can further treat the main cause of the most common form of cystic fibrosis.
